Appraisal of patient-reported outcome measures in analogous diseases and recommendations for use in phase II and III clinical trials of pyruvate kinase deficiency

por Salek, M. S., Ionova, T., Johns, J. R., Oliva, E. N.
Publicado 2018

P1705: PATIENT-REPORTED OUTCOMES IN MYELOPROLIFERATIVE NEOPLASMS IN CLINICAL TRIALS: A SYSTEMATIC REVIEW

por Oliva, E. N., Salek, S., Laane, E., Andreas, M., Csenar, M., Skoetz, N., Ionova, T.
Publicado 2022

P1725: OBSERVATIONAL STUDY TO EVALUATE PATIENT-REPORTED OUTCOMES IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

por Urciuoli, E., Di Bona, E., Greve, S., De Vivo, A., Sica, S., Fontana, R., Barcellini, W., Marano, L., Oliva, E. N.
Publicado 2022

A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes

por Platzbecker, U, Symeonidis, A, Oliva, E N, Goede, J S, Delforge, M, Mayer, J, Slama, B, Badre, S, Gasal, E, Mehta, B, Franklin, J
Publicado 2017